跳至主要内容
临床试验/NCT07258706
NCT07258706Enrolling By Invitation不适用

DIVER-TAVI Registry - Demographic and Interpopulation Variations in Evaluation and Results of TAVI

Poznan University of Medical Sciences5 个研究点 分布在 5 个国家目标入组 800 人开始时间: 2025年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
800
试验地点
5
主要终点
Aortic annulus diameter

研究概览

简要总结

The aim of the project is to evaluate demographic, clinical, and laboratory variations in patients with aortic stenosis treated with TAVI in different countries. Moreover, the study will evaluate interpopulation differences in aortic root anatomy based on computed tomography analysis.

详细描述

Aortic stenosis represents the most common valvular heart disease in developed countries, with a significant epidemiologic increase related to the aging population. Currently, surgical and transcatheter interventions are the only therapeutic options, as pharmacotherapy is still insufficient in the disease management. Transcatheter aortic valve implantation is recommended in selected groups of patients and provides optimal short and long-term outcomes.

Racial and ethnic disparities in aortic stenosis prevalence, management, and outcomes of treatment have been postulated. Data on discrepancies in aortic stenosis characteristics in patients qualified for transcatheter aortic valve implantation across populations are lacking.

The current project will conduct the analysis in populations of patients with aortic stenosis qualified for transcatheter aortic valve implantation from different countries to reveal potential disparities in clinical characteristics and in requirements for variations in prostheses sizes.

This is a retrospective, multicentre, observational registry of patients with severe aortic stenosis qualified for transcatheter aortic valve implantation.

Inclusion criteria - each site will include consecutive 100 patients who underwent transcatheter aortic valve implantation between January and June 2025.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Severe aortic stenosis qualified for TAVI

排除标准

  • Active infection (chronic inflammatory disease or neoplasm is not an exclusion criterion, however, will be considered in the laboratory analysis)

结局指标

主要结局

Aortic annulus diameter

时间窗: Baseline

Aortic annulus diameter in milimeters based on CT image

Aortic annulus area

时间窗: Baseline

Aortic annulus area in squared milimeters based on CT image

Aortic annulus perimeter

时间窗: Baseline

Aortic annulus perimeter in milimeters based on CT image

Ilio-femoral artery diameter

时间窗: Baseline

Ilio-femoral artery diameter in milimeter based on CT image

Neutrophils measured using whole blood count

时间窗: Baseline

This measurement is used to compute ratio of cell types using whole blood count

Monocytes measured in whole blood count

时间窗: Baseline

Number of monocytes identified in blood sample using automatic whole blood count. It is used to compute cell type ratio.

Lymphocytes measured using whole blood count

时间窗: Baseline

This measurement is used to compute ratio of cell types using whole blood count

次要结局

未报告次要终点

研究者

发起方
Poznan University of Medical Sciences
申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

进行中(未招募)
不适用
Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal- Tonsillitis in Pediatric Patients (DROPSPharyngotonsillitisMedDRA version: 17.1Level: PTClassification code 10049140Term: PharyngotonsillitisSystem Organ Class: 10021881 - Infections and infestations
EUCTR2014-004002-15-Outside-EU/EEASanofi210
进行中(未招募)
1 期
Clinical trial to evaluate a new combination of drugs (Filanesib + pomalidomide + dexamethasone) for the treatment of relapsed or refractory (drug-resistant) multiple myeloma.Patients with Multiple Myeloma in relapsed or refractoryMedDRA version: 17.1Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864
EUCTR2014-002740-41-ESFundación Pethema24
进行中(未招募)
1 期
Exploration if Saizen marketed solution for injection induces an immunogenic reactioAdult Growth Hormone DeficiencyMedDRA version: 17.1 Level: PT Classification code 10056438 Term: Growth hormone deficiency System Organ Class: 10014698 - Endocrine disorders
EUCTR2012-004263-47-GBMerck KGaA78
进行中(未招募)
不适用
Exploration if Saizen marketed solution for injection induces an immunogenic reactioAdult Growth Hormone DeficiencyMedDRA version: 17.1Level: PTClassification code 10056438Term: Growth hormone deficiencySystem Organ Class: 10014698 - Endocrine disorders
EUCTR2012-004263-47-CZMerck KGaA77
进行中(未招募)
不适用
Exploration if Saizen marketed solution for injection induces an immunogenic reactioAdult Growth Hormone DeficiencyMedDRA version: 17.1Level: PTClassification code 10056438Term: Growth hormone deficiencySystem Organ Class: 10014698 - Endocrine disorders
EUCTR2012-004263-47-SEMerck KGaA77